Top Healthcare Stocks
Healthcare stocks were sharply lower with the NYSE Healthcare
Sector Index plunging over 1.9% while shares of healthcare
companies in the S&P 500 dropped 2.2% as a group.
In company news, Shares of Uroplasty Inc. (
) rallied Friday, hitting a two-year high, after the maker of
medical devices to treat voiding dysfunctions reported a 14% jump
in fiscal third-quarter sales and forecast even stronger revenue
growth for the current quarter.
UPI was up 31.4% at $4.60 just before the closing bell, earlier
streaking to $5.40 a share, its highest level since October
For the quarter ended Dec. 31, the company posted a net loss of
$0.03 per share, unchanged from the year-ago loss. Excluding
one-time items, the company had an operating loss of about $277,000
in the latest quarter, compared with an operating loss of about
$135,000 in the year-earlier period. No analyst estimates were
available for comparison via Capital IQ.
Net sales climbed 14% to $6.4 million. Sales of its Urgent PC
Neuromodulation System in the U.S. jumped 19% to $3.2 million while
sales of Macroplastique in the U.S. rose 11% to $1.5 million. Total
net sales outside the U.S. increased 11% to $1.6 million.
For the ongoing fiscal fourth quarter, the company forecast
year-over-year revenue growth of 25% to 30%.
In other sector news,
(+) BDSI, Together with Endo Health Solutions Inc. (
), the drug-maker announces positive top-line results from Phase
III efficacy study of their BEMA buprenorphine for the treatment of
moderate to severe chronic pain in patients. ENDP was lower
(-) KIPS , Prices underwritten public offering of 5.525 mln
shares of its common stock at 70 cents each, generating $3.675 mln
gross proceeds. Net proceeds are slated for development, clinical
trials and seeking regulatory approval for the company's eSVS Mesh
in the U.S. and abroad.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.